Study S002020

A Randomized, Double-Blind, Placebo-Controlled, Single-Center Study of Efsubaglutide Alfa in Patients Remaining Obese 6 Months After Metabolic Surgery

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07163650
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 60
Start: 2025-09-16
Primary completion: 2026-11-30
Lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions: Obesity; Weight Loss; Metabolic Surgery
Interventions: DRUG:Efsubaglutide Alfa Injection; BEHAVIORAL:Diet and exercise guidelines
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in %TWL from baseline to endpoint [24 weeks from enrollment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.